title: Effects of arginine vasopressin and atriopeptin on chloride uptake in cultured astroglia.
abstract: Ion and water homeostasis in the CNS is subjected to a neuroendocrine control exerted by neuropeptides formed within the brain. In order to gain information on this neuroendocrine control of Cl- homeostasis, 36Cl- uptake was measured in cultured Type-I astrocytes exposed to the neuropeptides [Arg8]Vasopressin (AVP), and atriopeptin (AP) and to various Cl- transport modifiers. AVP increased while AP decreased 36Cl- uptake of cultured astrocytes in a dose-dependent manner. Both effects became statistically significant at greater than 10(-9) M concentration of the peptides. For the appearance of the effects at least 30-min exposure was necessary. AVP and AP extinguished each other's effect by almost stochiometric manner. When administered together with AVP, the VIA vasopressin receptor antagonist "Manning compound" inhibited, while V2 vasopressin receptor agonist did not influence the 36Cl- uptake-increasing effect of AVP. However, bumetanide, a specific inhibitor of Na+-K+-2Cl- cotransport, inhibited the effect of vasopressin and also inhibited the 36Cl- uptake of AVP non-treated, control cells. Our findings suggest that brain Cl- homeostasis is controlled by neuroendocrine system in the CNS.
authors.affiliation: Department of Neurology and Psychiatry, Albert Szent-Gyorgyi Medical University, Szeged, Hungary.
authors.forename: L
authors.initials: L
authors.lastname: Katay
authors.forename: L
authors.initials: L
authors.lastname: Latzkovits
authors.forename: A
authors.initials: A
authors.lastname: Fonagy
authors.forename: Z
authors.initials: Z
authors.lastname: Janka
authors.forename: A
authors.initials: A
authors.lastname: Lajtha
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001127:Arginine Vasopressin / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009320:Atrial Natriuretic Factor / Q000378:metabolism* / Q000494:pharmacology; D002034:Bumetanide / Q000494:pharmacology; D002352:Carrier Proteins / Q000037:antagonists & inhibitors; D002478:Cells, Cultured; D002712:Chlorides / Q000378:metabolism*; D004336:Drug Antagonism; D006727:Hormone Antagonists / Q000494:pharmacology; D051381:Rats; D017483:Receptors, Vasopressin / Q000187:drug effects; D028021:Sodium-Potassium-Chloride Symporters; D013997:Time Factors
chemical_list: D002352:Carrier Proteins; D002712:Chlorides; D006727:Hormone Antagonists; D017483:Receptors, Vasopressin; D028021:Sodium-Potassium-Chloride Symporters; D002034:Bumetanide; D001127:Arginine Vasopressin; C025043:vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine-; D009320:Atrial Natriuretic Factor